Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Net Margin (2019 - 2025)

Historic Net Margin for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to 8.58%.

  • Eton Pharmaceuticals' Net Margin fell 146500.0% to 8.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.19%, marking a year-over-year decrease of 26000.0%. This contributed to the annual value of 9.8% for FY2024, which is 68400.0% down from last year.
  • Per Eton Pharmaceuticals' latest filing, its Net Margin stood at 8.58% for Q3 2025, which was down 146500.0% from 13.66% recorded in Q2 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Net Margin peaked at 43.0% during Q1 2021, and registered a low of 786.32% during Q3 2021.
  • Moreover, its 5-year median value for Net Margin was 10.18% (2024), whereas its average is 70.15%.
  • Over the last 5 years, Eton Pharmaceuticals' Net Margin had its largest YoY gain of 235842700bps in 2021, and its largest YoY loss of 2000000000bps in 2021.
  • Over the past 5 years, Eton Pharmaceuticals' Net Margin (Quarter) stood at 17.05% in 2021, then crashed by -37bps to 10.73% in 2022, then plummeted by -171bps to 7.57% in 2023, then surged by 32bps to 5.13% in 2024, then crashed by -67bps to 8.58% in 2025.
  • Its Net Margin was 8.58% in Q3 2025, compared to 13.66% in Q2 2025 and 88.02% in Q1 2025.